Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Nothing | 2025 | Equity Crowdfunding | $8.0M | London |
| Allink Biotherapeutics | 2025 | Series A | $47.0M | Shanghai |
| Kind Pharmaceutical | 2025 | Series C | $56.2M | Hangzhou |
| Cornerstone Robotics | 2025 | Series Unknown | $200.0M | Hong Kong |
| WIZ.AI | 2025 | Series B | Undisclosed | Singapore |
| LibLib AI | 2025 | Series B | $130.0M | Beijing |
| Shexu Technology | 2025 | Series B | Undisclosed | Shanghai |
| M.AI Unbound, Inc | 2025 | Seed | $25.0M | Mountain View |
| CytoNiche | 2025 | Series B | Undisclosed | Beijing |
| Adaps Photonics | 2025 | Series C | $14.0M | Shenzhen |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | Nothing | Equity Crowdfunding | $8.0M | London, United Kingdom |
| 27 | Allink Biotherapeutics | Series A | $47.0M | Shanghai, China |
| 28 | Kind Pharmaceutical | Series C | $56.2M | Hangzhou, China |
| 29 | Cornerstone Robotics | Series Unknown | $200.0M | Hong Kong, Hong Kong |
| 30 | WIZ.AI | Series B | Undisclosed | Singapore, Singapore |
| 31 | LibLib AI | Series B | $130.0M | Beijing, China |
| 32 | Shexu Technology | Series B | Undisclosed | Shanghai, China |
| 33 | M.AI Unbound, Inc | Seed | $25.0M | Mountain View, United States |
| 34 | CytoNiche | Series B | Undisclosed | Beijing, China |
| 35 | Adaps Photonics | Series C | $14.0M | Shenzhen, China |
Nothing develops consumer electronics, including smartphones and earbuds, with a focus on connectivity and design.
Allink Biotherapeutics is a biopharmaceutical company that develops multi-specific antibodies for oncology and immunology treatment.
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
WIZ.AI provides conversational AI platforms and virtual agents that engage customers through voice and digital channels.
LibLib AI is an AI image generation platform that provides cutting-edge content creation through AI multi-dimensional interactions.
Shexu Technology is a technology company which develops automatic industrial design software products based on an AI computing engine.
Unified AI Agent built for Marketers
CytoNiche is a 3D bionic cell technology company.
Adaps Photonics is a manufacturer of high-performance photoelectric sensor chips.
ALLYRNA Pharmaceuticals is a biotechnology company focused on the research and development of innovative small molecule drugs.
MiAO aims to transform player interaction with digital content using advanced AI and cutting-edge content generation technologies.
Nova Fusion is an innovative company that provides commercialization of small modular nuclear fusion reactors.
Huayi Quantum is a quantum computer and quantum cloud platform developer.
Bosszhipin is a recruitment mobile app.
Biren Technology is an AI chip startup that develops intelligent processors for GPU and DSA computation architectures.
AkroStar is a semiconductor firm specializing in advanced semiconductor IP R&D and services.
eCloudTech is a cloud computing solution provider, dedicated to data center
Cholesgen is a biopharmaceutical company dedicated to developing innovative drugs.
HashKey Group is end-to-end digital asset financial services group that offers consulting on blockchain systems and products.
Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).
Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Zhongke Hydroyi focuses on the research and development of polymer diaphragm products.
Vision Travel Technology is an AI travel solution provider.
Gaorong Capital has invested in 171 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Gaorong Capital's top investment sectors include Artificial Intelligence (AI), Biotechnology, Software, Information Technology, Biopharma. The firm invests across 47 different industry categories.
Among tracked funding rounds, BOSS Zhipin received $280.2M in a Post Ipo Equity round. Gaorong Capital's total known invested capital is $7.3B.
Gaorong Capital's average investment size is $68.0M across its portfolio of 171 companies.
Recent Gaorong Capital portfolio additions include Nothing, Allink Biotherapeutics, Kind Pharmaceutical, Cornerstone Robotics, WIZ.AI. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors